Should You Buy Madison Square Garden Sports Corp (MSGS) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
285.640
1 Day change
-0.14%
52 Week Range
293.350
Analysis Updated At
2026/01/26
Madison Square Garden Sports Corp (MSGS) is not a strong buy for a beginner, long-term investor at this time. While the stock has bullish technical indicators and a discounted valuation according to some analysts, the lack of significant catalysts, declining revenue, and mixed sentiment from analysts suggest limited upside in the near term. The investor may consider holding off on investing until more favorable conditions arise or clear growth catalysts are identified.
Technical Analysis
The technical indicators show a bullish trend with the MACD above zero and positively contracting, RSI in the neutral zone at 74.521, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). The stock is trading near resistance levels (R1: 291.033, R2: 298.344), with support at 267.364. However, the pre-market price change (-0.69%) suggests slight downward pressure.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Technical Summary
Sell
3
Buy
9
Positive Catalysts
Analysts highlight the discounted valuation of MSGS compared to the private market value of its teams.
Citi raised the price target to $290, indicating potential upside.
Positive long-term secular tailwinds in the sports industry.
Neutral/Negative Catalysts
Wolfe Research downgraded the stock to Peer Perform, citing minimal catalysts to drive the stock higher.
Revenue dropped significantly (-25.99% YoY) in the latest quarter, indicating operational challenges.
The Dolan family's reluctance to sell stakes in the teams limits potential upside.
Financial Performance
In Q1 2026, revenue dropped by 25.99% YoY to $39.45M, while net income improved by 16.74% YoY to -$8.81M. EPS increased by 19.35% YoY to -$0.37, and gross margin declined by 6.20% YoY to 80.28%. Overall, the financial performance shows mixed results, with declining revenue but slight improvements in profitability metrics.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Analysts are mixed on MSGS. Citi maintains a Buy rating with a price target of $290, citing discounted valuation. Wolfe Research downgraded the stock to Peer Perform, citing limited catalysts. JPMorgan raised its price target to $240 with an Overweight rating, while Wolfe Research also lowered its price target to $268, citing a modest offseason miss.
Wall Street analysts forecast MSGS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSGS is 250 USD with a low forecast of 220 USD and a high forecast of 290 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast MSGS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSGS is 250 USD with a low forecast of 220 USD and a high forecast of 290 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 286.050
Low
220
Averages
250
High
290
Current: 286.050
Low
220
Averages
250
High
290
Citi
Steven Sheeckutz
Buy
maintain
$285 -> $290
AI Analysis
2025-12-16
Reason
Citi
Steven Sheeckutz
Price Target
$285 -> $290
AI Analysis
2025-12-16
maintain
Buy
Reason
Citi analyst Steven Sheeckutz raised the firm's price target on MSG Sports to $290 from $285 and keeps a Buy rating on the shares. Forbes indicated the average hockey team's value rose 15% year-over-year in 2025, the analyst tells investors in a research note. Citi believes the value of MSG Sports is is discounted to the company's underlying teams.
Wolfe Research
Peter Supino
Outperform -> Peer Perform
downgrade
2025-12-15
Reason
Wolfe Research
Peter Supino
Price Target
2025-12-15
downgrade
Outperform -> Peer Perform
Reason
Wolfe Research analyst Peter Supino downgraded MSG Sports to Peer Perform from Outperform without a price target. The company has "strong secular tailwinds" but minimal catalysts to move the shares higher, the analyst tells investors in a research note. Wolfe believes the equity upside from here relies on the Dolan family selling all or a minority stake in the teams, which is something they have never done.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MSGS
